← Back to patent-cliff list
Zabalafin hydrogel (Alphyn Biologics)
Tier C — Watch / tradeZabalafin hydrogel (Alphyn Biologics)
Alphyn Biologics Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Natural product / extract
Type
Targets：Cytokines
Indications (approved)：Eczema, Atopic dermatitis, 大疱性表皮松解症
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Zabalafin hydrogel (Alphyn Biologics)?
Approved indications include: Eczema, Atopic dermatitis, 大疱性表皮松解症.
When does the Zabalafin hydrogel (Alphyn Biologics) patent expire?
No public expiry year is available for Zabalafin hydrogel (Alphyn Biologics) yet; this page updates once verified.
How do I get a quote for Zabalafin hydrogel (Alphyn Biologics) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-30